Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Autoimmune Diseases × telitacicept × Clear all

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 3 Muscle Weakness 1 Autoimmune Diseases 1

Interventions

Data Collection 3 fludarabine 2 Cyclophosphamide 2 telitacicept 1 human papillomavirus vaccine, L1 type 16, 18 1 Watchful Waiting 1 Plasma Exchange 1 Phlebotomy 1 CT-P13 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05737160 2025-05-23

Study of Telitacicept in Generalized Myasthenia Gravis

RemeGen Co., Ltd.

Phase 3 Completed

Autoimmune Diseases, Myasthenia Gravis, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡